Rheumatoid arthritis is associated with a generalised loss of bone mass. One of the factors that have been implicated in the pathogenesis of this bone loss is the chronic use of non-steroidal anti-inflammatory drugs (NSAIDs). These drugs are known to increase gastrointestinal permeability and may thus influence the absorption of calcium; they may also influence glomerular filtration rate In patients with rheumatoid arthritis (RA) a generalised disturbance of bone metabolism has been described, leading ultimately to a loss of bone mass.' Bone tissue has both a mechanical and a metabolic role, but, when necessary, bone may be depleted of mineral in order to maintain calcium homeostasis. Extracellular calcium homeostasis is regulated by the absorption of calcium from the gut, the excretion of calcium by the kidneys, and the transport of calcium from bone into plasma.
Abstract
Rheumatoid arthritis is associated with a generalised loss of bone mass. One of the factors that have been implicated in the pathogenesis of this bone loss is the chronic use of non-steroidal anti-inflammatory drugs (NSAIDs). These drugs are known to increase gastrointestinal permeability and may thus influence the absorption of calcium; they may also influence glomerular filtration rate and the renal excretion of calcium; in addition, NSAIDs may inhibit osteoblast function as well as osteoclastic bone resorption.
Calcium homeostasis was studied in eight healthy volunteers during eight days' treatment with 150 mg indomethacin daily. No changes in serum concentration of calcium, phosphorus, parathyroid hormone, 25-hydroxyvitamin D3, and 1,25-dihydroxyvitamin D3 were found. The creatinine clearance and the urinary excretion of phosphorus and sodium did not change, but a decrease in calcium excretion was noted (mean (SEM) calcium/ creatinine excretion 0.52 (0.05) v 0-28 (0.06)). This decrease is probably due to renal retention of calcium. Whether this decrease of urinary calcium excretion has a positive or a negative effect on bone is presently unknown.
In patients with rheumatoid arthritis (RA) a generalised disturbance of bone metabolism has been described, leading ultimately to a loss of bone mass.' Bone tissue has both a mechanical and a metabolic role, but, when necessary, bone may be depleted of mineral in order to maintain calcium homeostasis. Extracellular calcium homeostasis is regulated by the absorption of calcium from the gut, the excretion of calcium by the kidneys, and the transport of calcium from bone into plasma.
In identifying risk factors for bone loss in patients with RA reduced mobility was found to be a potent factor that diminished bone mass. 2 Other factors have been implicated as well, such as the use of glucocorticosteroids and of non-steroidal anti-inflammatory drugs (NSAIDs). We investigated whether indomethacin had any influence on extracellular calcium homeostasis in healthy volunteers, and we found a decrease in renal excretion of calcium during indomethacin treatment.
Patients and methods After extensive explanation and with approval of the ethical committee of our hospital eight male medical students agreed to take part in the study. All were healthy, none had evidence of kidney dysfunction, hypertension, or gastrointestinal problems, none was taking any drugs. Mean age was 23 years (range 22-25). They were supplied with a diet with a fixed amount of calcium (30 mmol/day) and sodium (200 mmol/day), which remained unchanged during the whole study period.
On days 3 and 4 they were asked to pass 'fasting urine'-that is, they passed urine at 8 30 am, while in a fasting state, then drank 500 ml water, and their urine was collected during the following two hours. Blood samples were taken at 9 30 am. On day 5 the subjects started to take indomethacin 50 mg three times a day for eight days. On the last two days of this period sampling of blood and urine was repeated as in the control period. The following determinations were performed: (a) calcium in blood and urine by atomic absorption; the serum calcium concentration was corrected for the serum protein concentration (calcium corrected =calcium measured-(0 025x serum albumin g/l) + 1 mmol/l); (b) creatinine, inorganic phosphorus, and sodium in blood and urine by Technicon's AutoAnalyzer; (c) parathyroid hormone in serum by a two step radioimmunoassay that recognises the intact 1-84 parathyroid hormone molecule3; (d) 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 by competitive protein binding assays. 4 5 The excretion of calcium, phosphorus, and sodium in the urine was corrected for the creatinine excretion. It should be stressed, however, that our study relates to normal young volunteers during a relatively short period. It is possible that in older subjects or in patients with multisystem rheumatoid disease, who are using NSAIDs for a prolonged period, different results may be found.
